Hematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousTransplantation ConditioningGraft vs Host DiseaseStem CellsPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsBone Marrow TransplantationTransplantation ChimeraTissue DonorsTreatment OutcomeCord Blood Stem Cell TransplantationHematopoiesisGraft SurvivalMyeloablative AgonistsHistocompatibility TestingWhole-Body IrradiationHematopoietic Stem Cell MobilizationBusulfanHistocompatibilityAntigens, CD34Retrospective StudiesChimerismGraft vs Leukemia EffectLeukemiaLiver TransplantationRecurrenceCell DifferentiationBone Marrow CellsMesenchymal Stem Cell TransplantationImmunosuppressive AgentsRemission InductionHematologic DiseasesCombined Modality TherapyHepatic Veno-Occlusive DiseaseMultiple MyelomaHLA AntigensCell LineageSiblingsTime FactorsVidarabineUnrelated DonorsCell TransplantationLeukemia, Myeloid, AcuteMyelodysplastic SyndromesStem Cell NicheSurvival RateEmbryonic Stem CellsDisease-Free SurvivalGraft vs Tumor EffectAdult Stem CellsFlow CytometrySurvival AnalysisTransplantation ImmunologyMelphalanMice, Inbred C57BLKidney TransplantationSevere Combined ImmunodeficiencyLymphocyte TransfusionBone MarrowCyclophosphamideFetal BloodTransplantation, IsogeneicColony-Forming Units AssayPrecursor Cell Lymphoblastic Leukemia-LymphomaSalvage TherapyGranulocyte Colony-Stimulating FactorCytomegalovirus InfectionsAntilymphocyte SerumLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnemia, AplasticFollow-Up StudiesDonor SelectionAntineoplastic Combined Chemotherapy ProtocolsAllograftsT-LymphocytesLymphocyte DepletionAcute DiseaseCells, CulturedGraft RejectionCell SeparationMesenchymal Stromal CellsCell ProliferationPluripotent Stem CellsMultipotent Stem CellsOpportunistic InfectionsStem Cell FactorImmunosuppressionLymphoma, Non-HodgkinImmunocompromised HostLymphoproliferative DisordersOrgan TransplantationTransplantationHeart TransplantationPrognosisMice, SCIDLeukemia, Myeloid